Posted by Clinical Lab Products | Mar 5, 2010 | Cancer, Miscellaneous |
Abbott announced that it has entered into an agreement with GlaxoSmithKline (GSK) to develop a molecular diagnostic test intended for use as an aid in selecting patients who may benefit from a skin cancer treatment in development by GSK.
Read MorePosted by Clinical Lab Products | Feb 12, 2010 | Cancer, Miscellaneous, Pancreatic |
Specific chemical modifications to proteins called histones, which are found in the nucleus of cells and act as spools around which DNA is wound, can be used to predict prognosis and response to treatment in subsets patients with pancreatic cancer, according to a new study.
Read MorePosted by Clinical Lab Products | Feb 12, 2010 | Cancer, Miscellaneous |
Clarient Inc, a premier technology and services resource for pathologists, oncologists and the pharmaceutical industry, has announced the commercial launch of a new lung cancer test, Clarient Insight Dx Pulmotype.
Read MorePosted by Clinical Lab Products | Feb 10, 2010 | Cancer, Company News |
QIAGEN announced that its wholly owned subsidiary DxS has acquired the global and exclusive license for biomarker PI3K from Johns Hopkins University to develop real-time-PCR and endpoint PCR assays.
Read MorePosted by Clinical Lab Products | Jan 19, 2010 | Cancer, Miscellaneous |
Med BioGene Inc is pleased to announce that Michael R. Hayden, MD, PhD, FRCPC, has joined the company’s Board of Directors.
Read More